Vepured

RSS

E. coli verotoxoid vaccine (inactivated recombinant)

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Vepured.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Vepured.

For practical information about using Vepured, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 25/04/2019

Authorisation details

Product details
Name
Vepured
Agency product number
EMEA/V/C/004364
Active substance
recombinant Verotoxin 2e of E. coli
International non-proprietary name (INN) or common name
E. coli verotoxoid vaccine (inactivated recombinant)
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI09AB02
Publication details
Marketing-authorisation holder
Laboratorios Hipra, S.A.
Revision
1
Date of issue of marketing authorisation valid throughout the European Union
17/08/2017
Contact address

Avda. La Selva, 135
17170 Amer (Girona)
Spain

Product information

04/05/2018 Vepured - EMEA/V/C/004364 - IB/0001

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Immunologicals for suidae

  • inactivated bacterial vaccines (including mycoplasma
  • toxoid and chlamydia).

Therapeutic indication

Active immunisation of piglets from 2 days of age to prevent mortality and reduce clinical signs of oedema disease (caused by verotoxin 2e produced by E. coli) and to reduce the loss of daily weight gain during the finishing period in the face of infections with verotoxin 2e producing E. coli until slaughter from 164 days of age.

Assessment history

How useful was this page?

Add your rating